Inactive Instrument

Press Releases Adherex Technologies Inc. (USA) Other OTC

Equities

CA00686R4089

End-of-day quote Other OTC Other stock markets
- ^USD	-

15/05	HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating	MT
14/05	Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fennec Pharmaceuticals : Corporate Presentation May 2024	15/05	PU
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	14/05	GL
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024	08/05	GL
Fennec Pharmaceuticals : Corporate Presentation March 2024	31/03	PU
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update	21/03	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	19/03	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	19/03	AQ
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand	18/03	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	29/02	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	29/02	AQ
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	01/02	GL
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	01/02	AQ
Fennec Announces Incremental $5 Million Investment from Petrichor	05/12	GL
Fennec Announces Incremental $5 Million Investment from Petrichor	05/12	AQ
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	10/11	GL
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	10/11	AQ
Fennec Pharmaceuticals : Corporate Presentation November 2023	06/11	PU
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	06/11	GL
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	06/11	AQ
Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions	31/23/31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Adherex Technologies Inc. (USA) Other OTC

Equities

CA00686R4089

Press Releases

Filters